Revolutionizing adherent cell assays to unlock better treatments for high unmet clinical needs and enable new research paradigms
Semarion has developed a novel class of materials, called SemaCytes®. These micro-scale cell carriers are uniquely engineered with microchip fabrication, nanomagnetism, and smart materials.
The core of our innovation lies in turning adherent cells into liquid reagents. Along with features such as assay miniaturization, barcoding, and automation, this facilitates better quality and more reproducible data, while reducing the time and cost to deliver research outputs.
Location: United Kingdom, England, Cambridge
Employees: 1-10
Total raised: $2.91M
Founded date: 2018
Investors 3
| Date | Name | Website |
| - | Start Codo... | startcodon... |
| - | Parkwalk A... | parkwalkad... |
| 24.02.2022 | Martlet | martletcap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.02.2022 | Seed | $2.91M | Cambridge ... |
Mentions in press and media 11
| Date | Title | Description | Source |
| 18.10.2023 | Semarion announces Early Adopter Programme for SemaCyte Micr... | SemaCyte Microcarrier Platform addresses limitations within adherent cell assays to accelerate the p... | cambridgen... |
| 07.02.2023 | #21toWatch announces shortlist of next generation of Cambrid... | cofinitive have announced the shortlist for #21toWatch 2023 which this year contains an eclectic mix... | cambridgen... |
| 22.02.2022 | Semarion – closes Seed round | Parkwalk are delighted to announce an investment in Semarion, who are revolutionising in-vitro cell ... | parkwalkad... |
| 22.02.2022 | Semarion raises £2.14 million GBP ($2.89 million USD) seed f... | Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining mat... | cambridgen... |
| 22.02.2022 | Semarion Raises GBP£2.14M in Seed Funding | Semarion, a Cambridge, UK-based company combining materials engineering and cell biology to tackle u... | finsmes.co... |
| 22.02.2022 | Semarion raises £2.14 million GBP ($2.89 million USD) seed f... | Semarion raises £2.14 million GBP ($2.89 million USD) seed funding 22-02-2022 Semarion Ltd, a Univer... | cambridgen... |
| 22.02.2022 | Addressing foundational bottlenecks in drug discovery, Cambr... | University of Cambridge spin-out company Semarion has raised a £2.14 million seed funding. The round... | tech.eu/20... |
| 04.02.2022 | Annual #21toWatch announces shortlist in advance of return t... | Annual #21toWatch announces shortlist in advance of return to in-person awards event 04-02-2022 Next... | cambridgen... |
| 04.02.2022 | Annual #21toWatch announces shortlist in advance of return t... | Next month’s coveted #21toWatch Awards announces 2022 shortlist, featuring some of the most ground-b... | cambridgen... |
| 23.06.2020 | Shooting stars unveiled in Start Codon’s first contingent | Cambridge UK healthcare accelerator Start Codon has revealed its first cohort of early stage busines... | cic.vc/new... |
Show more